Clinical Evaluation of Panchamrit Lauha Guggulu and Panchguna Taila in the management of Cervical Spondylosis(Greeva Graha)

Ceneral Council For Research In Ayurvedic SciencesCCRAS0 个研究点目标入组 63 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients of either sex with age between 30 and 60 years.
•2.MRI Neck, findings suggestive of degenerative changes & cervical spondylosis.
•3.Patients with or without radiculopathy.
•4.Intermittent neck and shoulder pain.
•5.Restricted movement of neck.

•1.Age below 30 years and above 60 years
•2.Patients with cervical myelopathy.
•3.Patients with neck pain and other degenerative signs due to other reasons like spondylolysthesis, cervical spinal stenosis, diseases of atlanto-occipital joint, meningitis, atlantoaxial joint, muscle strain or soft tissue etiology, pregnancy, tumours, internal bleeding(haematoma)infection, injury, Pottâ??s disease etc.
•4.Patients with congenital cervical rib and acquired Spinal deformity(Pottâ??s fracture, compression fracture etc)
•5.Patients with poorly controlled Hypertension ( >160/100 mmHg)
•6. Patients with uncontrolled Diabetes Mellitus having Hb A1C of > 8%
•7.Patients on medication with corticosteroids, phototherapy, biologics, antidepressants any other drugs that may have an influence on the outcome of the study.
•8.Known cases of cardiovascular diseases, hepatic disorders, Renal Disorders, Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), Malignancy or any other condition that may jeopardize the study.
•9. Alcoholics and/or drug abusers/ chain smokers.
•10.Chronic Rheumatological and auto-immune diseases like RA, Psoriatic arthropathy, Gout, SLE.
•11.H/o hypersensitivity to any of the trial drugs or their ingredients.
•12.Patients who have completed participation in any other clinical trial during the past six months
•13.Any other condition which the Investigator thinks may jeopardize the study

发起方

Ceneral Council For Research In Ayurvedic SciencesCCRAS